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 • What is the prevalence and incidence of comorbidity/
multimorbidity?
 – For example, the prevalence and incidence of 
comorbidity of cancer taken from a general prac-
tice-based registration [6]
 • What are the patterns of multimorbidity?
 • In the case of different data sets, cross-national com-
parisons of disease patterns can be performed, such as 
the recent analysis of primary care electronic records 
in Spain and the Netherlands [7]
 • What is the impact of multimorbidity or specific 
comorbidities on patient outcomes?
 – An example includes the analysis of data from 
the Veterans Administration in the USA on the 
role of comorbidities in the prognosis of heart 
failure [8]. Another example is the impact of 
comorbid chronic conditions on the quality of 
diabetes care [9]
 – The Belgium BELFRAIL study, which comprised 
subjects aged 80 years and older, included medical 
histories reported by general practitioners in their 
database and also reported on multimorbidity as a 
predictor of adverse events [10]
 • What is the association between multimorbidity and 
related phenomena?
 – For example, the Swedish study that examined the 
association of disability in relation to multimorbid-
ity and disease clustering in older adults [11]
Introduction
Despite the high proportion and growing number of 
people with comorbidity/multimorbidity, clinical trials 
often exclude this group, leading to a limited evidence 
base to guide policy and practice for these individuals 
[1–5]. This evidence gap can potentially be addressed 
by secondary analysis of studies that were not origi-
nally designed to specifically examine comorbidity/
multimorbidity, but have collected information from 
participants on co-occurring conditions. For example, 
secondary data analysis from randomized controlled 
trials may shed light on whether there is a differential 
impact of interventions on people with comorbidity/
multimorbidity. Furthermore, data regarding comor-
bidity/multimorbidity can often be obtained from 
registration networks or administrative data sets. These 
types of data sets can address a range of epidemiological 
research questions, such as:
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 – Another example is an Australian study examining 
patterns of multimorbidity in relation to functional 
decline [12].
Many databases include information on (chronic) dis-
eases and are therefore available for further analysis of 
interesting and relevant issues related to comorbidity/
multimorbidity.
Why secondary data?
The purpose of using secondary data is to exploit the 
already available data and interpret them in new ways – 
beyond the research hypotheses for which the studies were 
designed. This enables researchers to explore specific ques-
tions that have not been adequately addressed and increases 
outputs and knowledge translation from funded research.
Preparation and submission of secondary data 
analyses
The Journal of Comorbidity is calling for submissions 
of original articles based on the analysis of secondary 
data (i.e. existing data resources). We are interested 
in a broad range of research related to comorbidity/
multimorbidity, and welcome secondary analyses using 
data from various sources, such as randomized trials 
and administrative, cross-sectional, and longitudinal 
data. Data sources may be small, such as regionally or 
locally based data sets, or large, nationally representa-
tive data sets.
We welcome original research of secondary analyses 
and invite submissions that specifically address issues rel-
evant to comorbidity or multimorbidity. Authors should 
consult the journal’s website (www.jcomorbidity.com) 
for guidelines on preparing and submitting their paper. 
The journal’s usual peer review, editorial processes, and 
standards will be followed.
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